Skip to main content
. 2021 Jun 23;9(7):689. doi: 10.3390/vaccines9070689

Figure 1.

Figure 1

Mechanism of anti-PD-1/PD-L1 and anti-CTLA-4 ICIs in anti-cancer therapy for NSCLC. Abbreviations: APC, antigen-presenting cell; TCR, T-cell receptor; MHC, major histocompatibility complex; PD-L1, programmed Death-Ligand 1; PD-1, programmed Cell Death Protein-1 (PD-1); CTLA-4, cytotoxic T-lymphocyte-associated protein 4.